Nancy Lee, MD
Memorial Sloan Kettering Cancer Center
Emerging Leaders
not ranked
Current Leaders
#4042 pts
All-Time Leaders
#1,83516 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2003. 10 trials as lead/chair. How it works →
Trials led — by scientific impact
Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma
Phase 2RecruitingMemorial Sloan Kettering Cancer Center
4
impact
A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma)
Phase 2ActiveMemorial Sloan Kettering Cancer Center
4
impact
Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer
Phase 3RecruitingMemorial Sloan Kettering Cancer Center
3
impact
A Phase II Study Of Intensity Modulated Radiation Therapy (IMRT) +/- Chemotherapy For Nasopharyngeal Cancer
Phase 2CompletedRadiation Therapy Oncology GroupStudy Chair
2
impact
A Pilot Study of Durvalumab (MEDI4736) With Tremelimumab in Combination With Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer
Phase 1CompletedMemorial Sloan Kettering Cancer Center
1
impact
A Phase II Study of Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center
1
impact
Development and Evaluation of Imaging Acquisition and Analysis Methods for Optimization of MRI and/or CT in Radiation Oncology Simulation, Treatment Planning, and Response Assessment
N/ARecruitingMemorial Sloan Kettering Cancer Center
1
impact
Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer With No Evidence of Disease on Post-Treatment Imaging
N/AActiveMemorial Sloan Kettering Cancer Center
1
impact
A Pilot Randomized Trial of Induction Cemiplimab With or Without Fianlimab in De-escalated Chemoradiation for Locoregionally Advanced Non-Metastatic Nasopharyngeal Carcinoma
Phase 1Not Yet RecruitingMemorial Sloan Kettering Cancer Center
0
impact
Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma
Phase 2RecruitingMemorial Sloan Kettering Cancer Center
0
impact
A Study of Using Plasma Circulating Cell Free Human Papillomavirus Deoxyribonucleic Acid to Screen (cf HPV DNA) for HPV-Related Oropharyngeal Cancer
N/AActiveMemorial Sloan Kettering Cancer Center
0
impact
RP-3500 (ATRi) + External Beam Radiotherapy (EBRT) for the Palliative Treatment of Metastatic Disease
Phase 2ActiveMemorial Sloan Kettering Cancer Center
0
impact
Pilot Randomized Clinical Trial of Geriatric Comanagement or Geriatric Guided Supportive Care for Older Patients With Head and Neck Cancer Receiving Radiation and Chemotherapy
N/ACompletedMemorial Sloan Kettering Cancer Center
0
impact
A Phase II Randomized Double-Blind Placebo-Controlled Clinical Trial Of Hydroxychloroquine For Prophylaxis Against Covid-19 In Patients Receiving Radiotherapy (COVID)
Phase 2TerminatedMemorial Sloan Kettering Cancer Center
0
impact
A Phase II Study of Proton Re-Irradiation for Recurrent Head and Neck Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center
0
impact
A Phase II Randomized Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer
Phase 2ActiveMemorial Sloan Kettering Cancer Center
0
impact
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
N/ACompletedMemorial Sloan Kettering Cancer Center
0
impact
A Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
N/ACompletedMemorial Sloan Kettering Cancer Center
0
impact